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Dendritic Epidermal T Cells: Lessons from Mice
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Dendritic epidermal T cells (DETC) in mice form part of a primitive system of epithelial-resident T cells characterized by the
expression of gd T-cell receptors (TCR). Critical attributes that characterize DETC include their highly restricted T-cell
receptor gene utilization, proliferation and maturation within epidermis, a capacity to kill relevant skin-derived tumor
targets, and the ability to modulate immune responses that are initiated and expressed in skin. Contemporary knowledge
suggests that DETC and the related skin-directed gd T cells found in humans play important roles in maintaining the
immunologic integrity of skin. J Invest Dermatol 100:80S–83S, 1993
In 1983, we and colleagues in Vienna reported an unusual population of
dendritic leukocytes that expressed Thy-1 antigen to reside in normal
mouse epidermis [1,2]. Not only did these cells exhibit features different
from that of dendritic epidermal Langerhans cells and melanocytes, it
was not possible at that time to place them with any certainty into an
established system of classification. Within ten years, however, our work
and the work of many others (reviewed in [3]) has led to an appreciation
that these cells, dendritic epidermal T cells (DETC), represent one
component of a primitive system of epithelial-resident T cells,
characterized by their expression of a gd T-cell receptor (TCR). This
review of contemporary knowledge about DETC places them into
context, that is, into the growing awareness that gd T cells as a class may
play critical roles in human disease. For a publication dedicated to the
memory of our esteemed colleague, it is instructive to recognize that
James N. Gilliam began his consuming interest in human autoimmune
disease while working with NZB/W mice, specifically with his
identification of antinuclear antibodies at the junction between dermis
and epidermis [4]. Not only did Gilliam encourage the study of this
unanticipated dendritic epidermal cell, he also recognized correctly that
knowledge about its ontogeny, phenotype, and function would lead to
new concepts concerning diseases that are expressed in skin. This brief
review of DETC is a tribute to that correct assessment and to the support
that followed.
CELL LINEAGE
Soon after the discovery of TCR g and d chains, we and others reported
that DETC also express these unique molecules [5,6], which until that
time were known to be expressed only by fetal thymocytes. Since then, it
has been established that gd T cells localize preferentially in epithelial
tissues, in marked contrast with the lymphoid organ-directed distribution
of conventional ab TCR-bearing T cells (reviewed in [7]). The list of
tissues that contain resident gd T cells now includes skin, intestine, lung,
reproductive tract, tongue, and mammary glands.
CELL SURFACE PHENOTYPE
DETC share with ab T cells several cell surface molecules, including
Thy-1, CD3, and CD45. DETC can be distinguished from conventional
T cells, however, by their lack of the ab TCR, CD4 and CD8 (molecules
associated during antigen presentation with major histocompatibility
complex [MHC] class II and class I molecules, respectively), and by their
unique expression of a gd TCR. DETC are also phenotypically distinct
from Langerhans cells, the other resident dendritic leukocytes, most
obviously by the lack of MHC class II molecules.
cd T-CELL RECEPTOR
The majority of T cells express a TCR consisting of a heterodimer of
a- and b- chain polypeptides, and they recognize antigens via this
receptor in the context of self-MHC molecules. TCRa and b genes
encode interchangeable segments in the V, D, J, and C regions of
germline DNA, and clonal diversity is generated during the course of
T-cell development by the selective use of each of these segments.
Moreover, pairing of a and b chains contributes to TCR diversity at the
protein level [8]. The TCR g and d loci share many a and b loci, also
permitting, at least theoretically, enormous receptor diversity [8]. A
striking early observation was that DETC display extremely restricted
gene usage and gd pairing: all DETC clones established in our laboratory
have demonstrated an identical TCR, composed of Vg3/Jgl-Cgl and Vdl/
Dd2/Jd2-Cd gene segments [5,9,10]. This feature has been confirmed at
in situ levels by Havran and Allison, who demonstrated, using monoclonal
antibodies (MoAb) specific to Vg3, that the overwhelming majority of
Thy-1þ , CD3þ epidermal cells do express this type of TCR [11].
ONTOGENY
Radiation chimera studies have demonstrated the bone marrow deriva-
tion of DETC [12]. Although athymic (nude) mice contain a significant
number of epidermal Thy-1þ leukocytes, they are phenotypically and
functionally distinct from those in euthymic mice, suggesting thymic
dependency for complete DETC development [13]. Supporting this
notion, the earliest fetal thymocytes express almost exclusively a TCR
containing Vg3, the identical TCR expressed by DETC [14]. Fetal thymic
origin of DETC has been demonstrated even more definitively by the
observation that intravenous injection of fetal thymocytes or transplanta-
tion of fetal thymic lobes results in reconstitution of Thy-1þ , CD3þ ,
TCR-Vg3/Vd1þ DETC in the epidermis of athymic mice [15,16]. The
unresolved question is whether skin-directed homing of fetal thymocytes
per se is sufficient for full development of DETC. In fact, this may not be
the case; newborn mouse skin contains only small numbers of Thy-1þ
epidermal cells, which increase thereafter and reach cell densities in
adult mice at about 1 month after birth [17]. More importantly, these
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Thy-1þ cells in neonatal skin are CD3 [18], and they appear to undergo
maturation to acquire this phenotype in the epidermal microenvironment
[18]. The exact mechanism by which DETC mature in skin remains to be
elucidated.
FUNCTIONAL PROPERTIES
Proliferative Responses DETC isolated from skin proliferate markedly in
response to conventional T-cell mitogens such as Con A, immobilized
anti-CD3 MoAb, or phorbol ester and calcium ionophore [19–21].
Moreover, a significant number of DETC in normal skin have the capacity
to undergo cell mitosis [22], and in situ proliferation becomes even more
apparent after topical application of irritant or allergic chemicals [23].
These results clearly illustrate the high proliferative potential of these
lymphocytes.
Cytokine Production As with ab T cells, DETC produce large amounts of
interleukin 2 (IL-2) following activational stimuli, presumably serving as
the major autocrine growth factor [24], They also produce g-interferon
(gIFN) but not IL-4 [20]. Our most recent study using the reverse
transcription-polymerase chain reaction suggests that DETC express a
variety of cytokine mRNAs upon stimulation. These include IL-1a, IL-2,
IL-3, IL-6, IL-7, IFNg, granulocyte/macrophage - colony-stimulating factor
(GM-CSF), tumor necrosis factor-a (TNFa), and TNFb [25]. In this regard,
it would be interesting to examine the biologic effects of these DETC-
derived cytokines on other epidermal cell populations (i.e., keratinocytes
and Langerhans cells).
Growth Factor Requirement Studies from our laboratory have demon-
strated progressive proliferative responses of mitogen-activated DETC to
IL-2, suggesting that IL-2 serves as the major growth factor for these
lymphocytes [19,24]. However, it appears unlikely that IL-2 is fully
responsible for the survival of DETC in normal skin, because IL-2 is
produced only by DETC, but not other epidermal cells and only after cell
activation [5,24,25]. We have begun to search for a relevant factor that is
constitutively present in the epidermal microenvironment and have
found that IL-7, which is produced by keratinocytes [26], possess a
capacity to sustain the survival and promote the growth of DETC (Matsue H,
Bergstresser PR, Takashima A: Keratinocyte-derived IL-7 serves as a
growth factor for dendritic epidermal T cells (manuscript submitted).
These results suggest that keratinocyte-derived cytokines serve as growth
factors, allowing these epidermal resident lymphocytes to survive in this
location, a notion similar to that which has been proposed for Langerhans
cells, the other epidermal leukocyte [27].
Cytotoxicity DETC lines and clones display non-MHC-restricted killing
activity against selected tumor targets, including the YAC-1 lymphoma
(NK-sensitive target) and an ultraviolet light (UVL) - induced fibrosarco-
ma [28,29]. Recently, we examined their target specificity and found that
DETC effectively lyse melanoma and transformed keratinocyte targets as
well [30]. DETC freshly isolated from normal skin, however, fail to
exhibit this cytotoxic activity; rather, they acquire this capacity in culture
after mitogenic stimulation and expansion in the presence of IL-2 [28].
Therefore, this activity resembles lymphokine-activated killer (LAK)
activity. In this regard, however, gd T cells freshly isolated from normal
mouse intestine display significant cytotoxicity, whereas cells from germ-
free mice fail to exhibit this potential, suggesting that cell activation (via
bacterial antigens in this case) leads to the acquisition of killing activity
[31]. It is possible to speculate from this that DETC in normal epidermis
have not been activated to become mature killer lymphocytes, but that
once activation is achieved they then become capable of killing tumor
cells, even in situ. The recent finding that DETCs in normal skin express
mRNA for perforin, a molecule responsible for the transmembrane
channel formation in target cells, supports this speculation [32].
Moreover, IL-7, which is known to enhance generation of LAK activity
in ab T cells, may promote locally the acquisition of killing activity by
these ‘‘activated’’ DETC.
Regulation of Epidermal Immune Response Unlike Langerhans cells,
which play a central role in the induction of contact hypersensitivity (CH)
and delayed-type hypersensitivity (DTH), DETC appear to downregulate
these responses. In fact, hapten-specific unresponsiveness can be
induced by intravenous infusion of hapten-derivatized DETC [33].
Furthermore, UVB radiation followed by hapten painting, a standard
protocol for inducing immunologic tolerance, results in the appearance
of haptenated Thy-1þ cells in draining lymph nodes; these cells possess a
downregulatory capacity [34]. Similarly, infusion of allogeneic DETC
leads to a failure of recipients to respond to the same alloantigen in a
subsequent challenge [35]. It has been shown in different mouse strains
that DETC density correlates inversely with the capacity of these animals
to mount CH responses [36]. Taken together, these studies suggest that
DETC are not only effector cells, but that they also may downregulate
immune responses that are initiated in skin.
Homing As already mentioned, gd T cells reside not only in epidermis,
but also in several other epithelial tissues. The most striking feature in this
respect is that cells in different tissues express predominantly different gd
TCR repertoires; Vg3-Vd1 in epidermis, Vg5-Vd2/4/5/6 in intestine, Vg2-
Vd5/6 in lung, and Vg4-Vd1 in the reproductive tract and tongue
(reviewed in [7]). These findings even suggest that TCR molecules
contribute to this tissue-specific homing. However, recent transgenic
mouse studies make this unlikely as epidermis is even populated by
DETC that express an incorrect transgenic gd TCR [37]. In our studies of
homing mechanisms, we have observed that DETC are capable of
migrating toward an undefined chemotactic activity secreted by
keratinocytes (Chung, Bergstresser, and Takashima: unpublished ob-
servations), and they bind selectively to keratinocyte monolayers [38].
These results, together with the finding that DETC bind to several
extracellular matrix proteins via integrin-like receptors [39], suggest that
DETC possess a unique capacity to migrate through dermal connective
tissue toward the epidermis and to reside among multilayered
keratinocytes in this location. This scenario is supported by our recent
observation that DETC isolated from the skin, when infused intrave-
nously, will then home preferentially to the skin (and thymus) but not to
other epithelial tissues [40].
Antigen Recognition The lack of diversity in TCRs expressed by DETCs
implies that the antigen(s) or ligand(s) recognized by these receptors is
highly restricted. Thus, DETC may recognize a set of rather limited
molecules that are expressed commonly and/or frequently in the
epidermal microenvironment. gd T-cell clones that specifically recognize
MHC-like molecules, heat shock proteins (HSP), and mycobacterial
antigens have been established from mice as well as humans, strongly
supporting this notion [41–43]. Asarnow et al have suggested that DETC
may recognize HSP or stress proteins [10], a highly conserved protein
family produced by virtually all cell types in response to stressful stimuli
(i.e., heat, starvation, infection, or malignant transformation) (reviewed in
[44]). It is also of interest that some eukaryotic cell HSP possess striking
sequence homology to mycobacterial antigens. An attractive scenario
drawn from this information would be that DETC recognize HSP or
related molecules expressed by ‘‘stressed’’ epidermal cells, thereby
leading to an activation of DETC that allows them to eliminate otherwise
harmful, neighboring cells. A recent study by Havran et al has provided
the first evidence for this hypothesis by demonstrating that DETC
activation is inducible through co-culture with transformed keratino-
cytes, that this activity can be transferred to other lymphocytes by
transfection with Vg3/Vdl genes, and that it can be blocked by anti-Vg3
Moabs [45]. Obviously, further studies are required to identify the
ligand(s) recognized by this receptor.
PHYSIOLOGIC ROLES AND POSSIBLE
CONTRIBUTION TO HUMAN SKIN DISORDERS
An obvious question has been whether human epidermis also contains
a similar gd T-cell network. The current consensus is that a DETC
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equivalent does not occur, in the sense that cells with dendritic
morphology, selectively localized in epidermis, and with restricted
TCR diversity have not been found. On the other hand, gd T cells as a
distinct subset of immunocompetent cells have been associated with the
pathogenesis of several human diseases, including some that involve
skin. The appearance of gd T cells in selected skin disorders, in turn,
suggests that human gd T cells do play important roles in maintaining the
immunologic integrity of skin.
Infection Modlin et al provided the first evidence that gd T cells play a
role in infectious skin disorders. Several types of skin lesions in leprosy
(i.e., lepromin test sites, representing the DTH reaction to M. leprae) are
infiltrated predominantly by gd T cells, which specifically recognize
mycobacterial antigens and which display strikingly limited diversity in
their TCR gene rearrangement [41,46]. Similar observations have been
made in localized cutaneous leishmaniasis [41]. Based on these findings,
it is reasonable to postulate that DETC (and other gd T cells) may function
as a first line of defense against infectious pathogens, whereas ab T cells
appear to serve as a second line after the latent period required for clonal
expansion [47,48].
Autoimmunity gd T cells that recognized mycobacterial antigens have
been recovered from synovial fluid in patients with rheumatoid arthritis
[3]. One may further speculate that those gd T cells cross-recognize
autologous HSP expressed in response to local tissue damages caused by
autoimmune attack [42]. In this regard, Shiohara et al have made the
important observation that following the severe epidermal damage that is
induced by the injection of autoreactive, ab TCR-bearing cytotoxic
T cells, recipient skin sites then become resistant to a second challenge
with the same T cells. This resistance is associated with a marked
increase in DETC densities at the site of injection [49]. An attractive
hypothesis is that DETC play a suppressive role, competing with the ab
T cells that act as effectors in this model of autoimmunity.
Tumors As mentioned previously, DETC possess a potential to kill
skin-derived tumor targets, including fibrosarcomas and melanomas.
Bachelez et al recently found that both ab T cells and gd T cells infiltrate
human melanoma skin lesions and that gd T-cell lines established from
these lesions display significant killing of autologous melanoma cells
[50]. These observations again reinforce the notion that the physiologic
function of DETC (and other epithelial gd T cells) may be to eliminate
‘‘stressed,’’ damaged, or transformed cells.
Taken as a whole, this contemporary knowledge about functional
attributes of DETC in mice and the related skin-directed gd T cells found
in humans suggests strongly that they play important roles in maintaining
the immunologic integrity of skin.
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